Current position: About Us > Milestones
Chairman's AddressOverviewMilestonesGuobang CultureHonorsGroup members
guobang
Milestones
Establish business, develop a country
Milestones
In March 1996
Guobang Pharmaceutical was established in Xinchang, committing to serving life and health.
In October 2000
Zhejiang Guobang Pharmaceutical Co., Ltd. was founded, building a research and production base mainly for raw materials in the Hangzhou Bay National Industrial Park.
In December 2006
Shandong Guobang Pharmaceutical Co., Ltd. was established, creating a leading research and production base for key pharmaceutical intermediates and animal health products in the national industrial park of Weifang, Shandong.
In February 2017
Zhejiang Zhongtong Pharmaceutical Co., Ltd. was founded, extending the company's business into the field of pharmaceutical preparations.
In October 2019
Guobang Pharmaceutical held the founding meeting of the joint-stock company and completed the shareholding system reform.
In August 2021
Guobang Pharmaceutical was listed on the main board of the Shanghai Stock Exchange, embarking on a new development journey.
In June 2022
the Hangzhou operation center of Guobang Pharmaceutical was launched, laying out the integration strategy.
In July 2023
Guobang Life Science and Technology Industrial Park was completed and put into use, aiming to build a global industrial base for research, production, trade and manufacturing of food and drug dual-purpose products.
In August 2023
Qifang Cup beverages and Guobang Nutrition achieved batch production, exploring the healthy application of functional nutritional products.
In July 2024
Quzhou Guoyi Fangcaodi Resort Hotel began operation, deepening the layout of rehabilitation and health care industries in the field of life and health.
In May 2025
the Research and Application Center for Health Active Substances was established, dedicated to the innovative research and development of high-end small molecule new drugs.
In September 2025
a comprehensive strategic cooperation was reached with Zhejiang Provincial State-owned Capital Operation Co., Ltd., promoting the quality improvement and upgrading of the biopharmaceutical industry.